Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized clinical trial of CFP versus CMFP in women with metastatic breast cancer.
Marschke RF Jr, Ingle JN, Schaid DJ, Krook JE, Mailliard JA, Cullinan SA, Pfeifle DM, Votava HJ, Ebbert LP, Windschitl HE. Marschke RF Jr, et al. Among authors: windschitl he. Cancer. 1989 May 15;63(10):1931-7. doi: 10.1002/1097-0142(19890515)63:10<1931::aid-cncr2820631011>3.0.co;2-f. Cancer. 1989. PMID: 2649221 Clinical Trial.
Combination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis.
Ingle JN, Twito DI, Schaid DJ, Cullinan SA, Krook JE, Mailliard JA, Tschetter LK, Long HJ, Gerstner JG, Windschitl HE, et al. Ingle JN, et al. Among authors: windschitl he. Cancer. 1991 Feb 15;67(4):886-91. doi: 10.1002/1097-0142(19910215)67:4<886::aid-cncr2820670405>3.0.co;2-o. Cancer. 1991. PMID: 1991261 Clinical Trial.
A double-blind trial of tamoxifen plus prednisolone versus tamoxifen plus placebo in postmenopausal women with metastatic breast cancer. A collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic.
Ingle JN, Mailliard JA, Schaid DJ, Krook JE, Gesme DH Jr, Windschitl HE, Pfeifle DM, Etzell PS, Gerstner JG, Long HJ, et al. Ingle JN, et al. Among authors: windschitl he. Cancer. 1991 Jul 1;68(1):34-9. doi: 10.1002/1097-0142(19910701)68:1<34::aid-cncr2820680107>3.0.co;2-q. Cancer. 1991. PMID: 2049750 Clinical Trial.
Chemotherapy for hormonally refractory advanced prostate carcinoma. A comparison of combined versus sequential treatment with mitomycin C, doxorubicin, and 5-fluorouracil.
Laurie JA, Hahn RG, Therneau TM, Patel SR, Mailliard JA, Windschitl HE, Twito DI, Morton RF, Krook JE. Laurie JA, et al. Among authors: windschitl he. Cancer. 1992 Mar 15;69(6):1440-4. doi: 10.1002/1097-0142(19920315)69:6<1440::aid-cncr2820690622>3.0.co;2-9. Cancer. 1992. PMID: 1540881 Clinical Trial.
Randomized clinical trial of high-dose levamisole combined with 5-fluorouracil and leucovorin as surgical adjuvant therapy for high-risk colon cancer.
O'Connell MJ, Sargent DJ, Windschitl HE, Shepherd L, Mahoney MR, Krook JE, Rayson S, Morton RF, Rowland KM Jr, Kugler JW. O'Connell MJ, et al. Among authors: windschitl he. Clin Colorectal Cancer. 2006 Jul;6(2):133-9. doi: 10.3816/ccc.2006.n.030. Clin Colorectal Cancer. 2006. PMID: 16945169 Clinical Trial.
Phase II trial of irinotecan in patients with metastatic colorectal carcinoma.
Pitot HC, Wender DB, O'Connell MJ, Schroeder G, Goldberg RM, Rubin J, Mailliard JA, Knost JA, Ghosh C, Kirschling RJ, Levitt R, Windschitl HE. Pitot HC, et al. Among authors: windschitl he. J Clin Oncol. 1997 Aug;15(8):2910-9. doi: 10.1200/JCO.1997.15.8.2910. J Clin Oncol. 1997. PMID: 9256135 Clinical Trial.
49 results